BANK VONTOBEL/CALL/STRYKER CORP./380/0.1/20.09.24 Share Price

Warrant

DE000VM9PP76

Market Closed - Deutsche Boerse AG 19:05:09 19/06/2024 BST
0.49 EUR +19.51% Intraday chart for BANK VONTOBEL/CALL/STRYKER CORP./380/0.1/20.09.24
Current month+28.12%
1 month+78.26%
Date Price Change
19/06/24 0.49 +19.51%
18/06/24 0.41 +13.89%
17/06/24 0.36 +12.50%
14/06/24 0.32 0.00%
13/06/24 0.32 -13.51%

Delayed Quote Deutsche Boerse AG

Last update June 19, 2024 at 07:05 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM9PP7
ISINDE000VM9PP76
Date issued 02/02/2024
Strike 380 $
Maturity 20/09/2024 (93 Days)
Parity 10 : 1
Emission price 1.14
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.72
Lowest since issue 0.163
Spread 0.03
Spread %5.77%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
348.7 USD
Average target price
372.9 USD
Spread / Average Target
+6.96%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW